An Evaluation of the Quick Inventory of Depressive Symptomatology and the Hamilton Rating Scale for Depression: A Sequenced Treatment Alternatives to Relieve Depression Trial Report

摘要: Background Nine DSM-IV-TR criterion symptom domains are evaluated to diagnose major depressive disorder (MDD). The Quick Inventory of Depressive Symptomatology (QIDS) provides an efficient assessment these and is available as a clinician rating (QIDS-C 16 ), self-report (QIDS-SR in automated, interactive voice response (IVR) (QIDS-IVR ) telephone system. This report compares the performance three versions QIDS 17-item Hamilton Rating Scale for Depression (HRSD 17 ). Methods Data were acquired at baseline exit from first treatment step (citalopram) Sequenced Treatment Alternatives Relieve (STAR*D) trial. Outpatients with nonpsychotic MDD who completed all four ratings within ±2 days identified 1500 STAR*D subjects. Both item theory classical test analyses conducted. Results methods obtaining data produced consistent findings regarding relationships between nine overall depression, demonstrating interchangeability among methods. HRSD , while generally satisfactory, rarely utilized full range scores, evidence suggested multidimensional measurement properties. Conclusions In outpatients without overt cognitive impairment, depression severity using either QIDS-C or may be successfully replaced by IVR version QIDS.